英国InforSense  www.inforsense.com
InforSense是一家总部设在英国伦敦的私人公司，北美总部在马萨诸塞州的剑桥市。InforSense的下一代商务智能分析平台提供了一整套高度灵活、可预知和可视化解决方案，能够帮助需要进行数据分析的组织将自己的数据源、信息处理工具和分析工具有机地加以整合，从而获取并更好地组织他们的决策制定流程。我们的顾客涵盖全球领先的制药，生物科技，消费品，健康，金融服务，制造和物流企业，为它们提供迅速，可靠的数据分析和预测服务。
InforSense provides a suite of highly agile, predictive and visual enterprise business intelligence and reporting software.
InforSense was founded in 1999 to commercialize pioneering, award-winning technology in the fields of High Performance Computing and Large Scale Data Mining developed at Imperial College, London. InforSense is a private company based in London, UK with additional offices in Cambridge, MA, USA and Shanghai, China.
InforSense’s core expertise lies in the development of a generic, horizontal, high performance business and scientific intelligence and Web-based reporting platform. This platform enables organizations to integrate, automate and visualize data sources, information and analysis processes to deliver significantly improved productivity, performance and breakthrough predictive insights.
InforSense goes beyond traditional business intelligence by enabling predictive analytics from a variety of data and text sources to be embedded into any third party application software or hardware, and delivered to users entirely over the Web.
Locations
InforSense is a fast growing worldwide organization with European headquarters in London UK and USA headquarters in Cambridge, Massachusetts. InforSense provides a truly global support network for clients through sales, marketing and support functions in the UK, USA, Germany and Japan, and technical development bases in the UK and Shanghai, China.

Markets and Customers
InforSense technology has a proven record of delivering value to a great variety of business enterprises. InforSense solutions address a range of industries, from life sciences and healthcare to financial services and sales & marketing analytics.
Amongst our customers are some of the most prestigious Fortune 500 companies, including the world's top pharmaceutical companies and research institutes as well as financial institutions.
Investors
Major shareholders include Elaia Partners, Fleming Family and Partners, Imperial Innovations Ltd, NPI Ventures (a subsidiary of Nikko Cordial Corporation), and Sitka Health Fund (VCT) plc.